Envoy Medical (COCH) Net Cash Flow Growth (3y) (2024 - 2026)
Envoy Medical (COCH) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | -48.90% |
| 10 | Envoy Medical | 47.39 Mn | 22.14 Mn | -274,000.00 | 184.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.93% |
| Dec 31, 2025 | 34.55% |
| Sep 30, 2025 | -37.80% |
| Jun 30, 2025 | -27.36% |
| Mar 31, 2025 | -98.18% |
| Dec 31, 2024 | 47.39% |
| Sep 30, 2024 | 79.54% |
| Jun 30, 2024 | -97.51% |
| Mar 31, 2024 | -30.08% |